ArticleBritish journal of cancer2004
The relationship between interleukin-6 and C-reactive protein in patients with benign and malignant prostate disease.
Article in British journal of cancer, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.
- A systematic review of the association between circulating concentrations of C reactive protein and cancer.Journal of epidemiology and community health · 2007Pooled it
- Trial
- Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality.International journal of cancer · 2009Trial
- Changes in Inflammatory Markers in Patients Treated for Buruli Ulcer and Their Ability to Predict Paradoxical Reactions.The Journal of infectious diseases · 2023Article
- Systemic and local vascular inflammation and arterial reactive oxygen species generation in patients with advanced cardiovascular diseases.Frontiers in cardiovascular medicine · 2023Article
- Extracorporeal Blood Purification in Moderate and Severe COVID-19 Patients: A Prospective Cohort Study.Blood purification · 2022Observational
- Optimisation of anti-interleukin-6 therapy: Precision medicine through mathematical modelling.Frontiers in immunology · 2022Article
- Modeling Approach to Predict the Impact of Inflammation on the Pharmacokinetics of CYP2C19 and CYP3A4 Substrates.Pharmaceutical research · 2021Article
- The Impact of Resveratrol Supplementation on Inflammation Induced by Acute Exercise in Rats: Il6 Responses to Exercise.Iranian journal of pharmaceutical research : IJPR · 2019Article
- Pretreatment C-reactive protein/albumin ratio is associated with poor survival in patients with stage IB-IIA cervical cancer.Cancer medicine · 2018Article
- Drug discovery in advanced prostate cancer: translating biology into therapy.Nature reviews. Drug discovery · 2016Review
- The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer.Chinese journal of cancer · 2015Article
- New prognostic score for the survival of patients with esophageal squamous cell carcinoma.Surgery today · 2014Article
- Semen quality and associated reproductive indicators in middle-aged males: the role of non-malignant prostate conditions and genital tract inflammation.World journal of urology · 2013Article
- Presence of tumoural C-reactive protein correlates with progressive prostate cancer.Prostate cancer and prostatic diseases · 2011Article
- C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older.Cancer causes & control : CCC · 2009Article
- Factors affecting adherence to a raw vegan diet.Complementary therapies in clinical practice · 2008Article
- The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer.British journal of cancer · 2005Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The relationship between interleukin-6 and C-reactive protein was evaluated in patients with benign (n=59) and malignant (n=86) prostate disease. The correlation coefficients for patients with benign prostatic disease and prostate cancer were rs=0.632, P<0.001 and rs=0.663, P<0.001, respectively. These results indicate that the relationship between interleukin-6 and C-reactive protein is similar in patients with benign and malignant prostate disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.